World Hepatitis Day 2020 image

Statement from the National Association of County and City Health Officials on World Hepatitis Day

Jul 27, 2020 | Andrea Grenadier

Statement from the National Association of County and City Health Officials on World Hepatitis Day

July 28, 2020

The National Association of County and City Health Officials (NACCHO), on behalf of the nearly 3,000 local health departments across the country, recognizes World Hepatitis Day, acknowledging the magnitude and impact of viral hepatitis, which causes significant illness and kills more Americans than any other infectious disease. Local health departments are leaders in the fight against viral hepatitis, engaged in surveillance, prevention, diagnosis, and treatment of viral hepatitis.

Tools to eliminate viral hepatitis in the United States include highly-effective vaccines against hepatitis A (HAV) and B (HBV); harm reduction strategies that could prevent half of hepatitis C cases (HCV); and curative treatments for HCV that can prevent deaths and further transmission. However, social and structural barriers to viral hepatitis services are driving a dramatic rise in HCV and widespread outbreaks of HAV. Moreover, additional investments are needed to scale up services and address the root causes of hepatitis and the inequities that define its distribution and impact in the U.S.

“While the nation is focused on addressing the COVID-19 pandemic, the spread of viral hepatitis continues,” said Lori Tremmel Freeman, NACCHO’s Chief Executive Officer. “We have the tools to eliminate viral hepatitis in the U.S., but social and structural barriers, stigma and discrimination, and insufficient funding limit access to prevention, diagnosis, and care. We need to redouble our efforts to support the work of local health departments to continue their work to prevent the spread and cure those infected.”

In 2017, the National Academies of Science, Engineering, and Medicine released a groundbreaking report declaring the feasibility of hepatitis elimination in the U.S., laying out a plan for the elimination of HBV and HCV. However, since then, cases have continued to rise. More than 30 states have reported outbreaks of HAV since 2016, and injection drug use has advanced the spread of HBV and HCV, resulting in a four-fold increase in HCV cases and state-level increases in HBV in the states hit hardest by the opioid epidemic.

Despite the availability of highly effective vaccines against HAV and HBV, vaccine coverage remains low: less than 10% of adults are vaccinated against HAV and only 25% of adult are vaccinated against HBV in the U.S. Half of people living with HCV and two-thirds of those

living with HBV don’t know their status, demonstrating the need for routine testing. While HCV can now be cured with limited side effects in less than three months, many people are unable to access this costly treatment. Putting the U.S. on a path toward hepatitis elimination would cost $3.9 billion over 10 years—an investment which would save the U.S. $6.5 billion annually. And yet, the Centers for Disease Control and Prevention receives less than 10% of what it needs to fund its work against viral hepatitis, a trend that is mirrored at the local level

These gaps in prevention, testing, and care are driven by social and structural barriers that limit access to viral hepatitis services: people who use drugs, people experiencing unstable housing or homelessness, people who are currently or were recently incarcerated, and men who have sex with men are all disproportionately affected by viral hepatitis in the U.S. These populations also face heightened stigma, discrimination, and other barriers when seeking healthcare.

While syringe services programs can prevent half of new HCV cases, many jurisdictions ban such programs, based on incorrect assumptions about their safety and efficacy. Even in those places with established programs, pandemic-related social distancing procedures and resources constraints also pose unique challenges to these important programs. People experiencing unstable housing or homelessness report substantial unmet health needs and may not be able to consistently utilize sanitation and hygiene practices that could protect them from HAV. The prevalence of HCV in U.S. prisons ranges from 10 to 40%, compared to a national prevalence of 1%. This drives community spread, with HCV prevalence 10-20 times higher in communities near correctional facilities. Yet the criminal justice system fails to provide viral hepatitis services—with less than 1% of HCV-positive inmates accessing treatment in state prisons —and the stigma associated with a criminal record impedes access to employment, and in turn health insurance.

For more information about NACCHO’s infectious disease program initiatives, visit its HIV, STI, and Viral Hepatitis webpage.




About Andrea Grenadier

More posts by Andrea Grenadier

Related Posts

Opportunity
  • Funding Opportunity Health Equity & Social Justice

RFA: Resilience Catalysts in Public Health Pilot Program

Applications due December 31, 2024.

Dec 05, 2024 | Alexandra Halprin

RFA: Resilience Catalysts in Public Health Pilot Program

Undefined
  • Tools & Resources Immunization Influenza

#FightFlu: Protecting Communities from Influenza Through...

National Influenza Vaccination Week (NIVW) is a reminder to all Americans 6...

Dec 02, 2024 | Victoria Thompson

#FightFlu: Protecting Communities from Influenza Through...

I Stock 1455947949
  • Community Health COVID-19 Immunization Influenza

Libraries: A Community Hub for Vaccine Education and...

The Van Buren/Cass District Health Department partnered with the district...

Nov 18, 2024 | Clarissa Montes

Libraries: A Community Hub for Vaccine Education and...

Man drinking water riding bicycle jogging on healthy food
  • Cardiovascular Health Community Health Opportunity

Building Healthier Hearts: Join NACCHO’s Community of...

Join the Community of Practice for Equity in Heart Health to advance heart...

Nov 18, 2024 | Johanna Segovia

Building Healthier Hearts: Join NACCHO’s Community of...

I Stock 122269077 1 1 1
  • Emergency Response Maternal, Child, & Adolescent Health Opportunity Training

Now Recruiting for NACCHO’s Virtual Learning...

New opportunity designed to cross-train maternal and child health and emergency...

Nov 14, 2024 | Elana Filipos

Now Recruiting for NACCHO’s Virtual Learning...

I Stock 1450377196
  • Community Health COVID-19 Immunization Vaccine Hesitancy

Strengthening Local Health Departments: Building and...

Collaborating with faith-based partners to improve COVID-19 and routine vaccine...

Nov 14, 2024 | Tori Ryan

Strengthening Local Health Departments: Building and...

I Stock 1534530569
  • Immunization

Enhancing Vaccine Access Through Targeted Outreach and...

Vernon Department of Health & Environmental Control partnered to integrate...

Nov 12, 2024 | Clarissa Montes

Enhancing Vaccine Access Through Targeted Outreach and...

53156858786 5fd9d76df2 k
  • AmeriCorps Community Health NACCHO 360 Workforce Development

NACCHO Welcomes Public Health AmeriCorps Scholarship...

NACCHO welcomed over 80 members of Public Health AmeriCorps to its annual...

Nov 08, 2024 | Vicki Lee

NACCHO Welcomes Public Health AmeriCorps Scholarship...

8 Shared Palnning and Strategic Plans
  • Funding Opportunity Community Health

FUNDING OPPORTUNITY: Youth and Community Violence...

NACCHO will provide up to $50,000 each for a maximum of 6 awardees to support...

Nov 05, 2024 | Bailey McInnes

FUNDING OPPORTUNITY: Youth and Community Violence...

Back to Top